{"id":72118,"date":"2026-05-26T12:22:56","date_gmt":"2026-05-26T16:22:56","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/brazil-clears-first-generic-version-of-popular-diabetes-drug-ozempic\/"},"modified":"2026-05-26T12:22:56","modified_gmt":"2026-05-26T16:22:56","slug":"brazil-clears-first-generic-version-of-popular-diabetes-drug-ozempic","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/brazil-clears-first-generic-version-of-popular-diabetes-drug-ozempic\/","title":{"rendered":"Brazil Clears First Generic Version of Popular Diabetes Drug Ozempic"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n

Brazil’s health regulatory agency Anvisa announced Tuesday that it has cleared EMS’s Ozivy, marking the first semaglutide injection pen approved in the country as the pharmaceutical company seeks to enter a more premium market segment.<\/p>

The medication contains the same active compound found in Novo Nordisk’s diabetes and weight-loss treatment Ozempic, which lost patent protection in Brazil this past March.<\/p>

Production of the drug will take place at an EMS facility located in Sao Paulo state, with manufacturing capability reaching as many as 40 million injection pens annually.<\/p>

The CEO of Grupo NC, EMS’s parent company, had previously informed Reuters in March that the company anticipated bringing semaglutide pens to market during this year.<\/p>

While regulatory approval has been secured, the medication cannot be sold until Brazil’s medicine pricing authority establishes a maximum price point.<\/p>

To become part of Brazil’s government-run healthcare program SUS, Ozivy requires additional clearance from the Health Ministry.<\/p>

Anvisa is currently evaluating five additional synthetic semaglutide submissions along with one biological variant.<\/p>

Competing pharmaceutical company Hypera had also announced intentions to introduce its own generic semaglutide product this year.<\/p>","protected":false},"excerpt":{"rendered":"

Brazil’s health authority has given the green light to the country’s first generic version of the diabetes and weight-loss medication that uses the same active ingredient as Ozempic. The approval comes after the original drug’s patent protection ended in Brazil earlier this year.<\/p>\n","protected":false},"author":4,"featured_media":72117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-72118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779812575858.png?fit=1920%2C1080&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-iLc","jetpack-related-posts":[{"id":35381,"url":"https:\/\/tvdelmarva.com\/wp\/brazilian-pharmaceutical-giant-plans-global-expansion-after-major-acquisition\/","url_meta":{"origin":72118,"position":0},"title":"Brazilian Pharmaceutical Giant Plans Global Expansion After Major Acquisition","author":"Admin","date":"March 12, 2026","format":false,"excerpt":"Brazilian drugmaker EMS is planning international expansion following its $500+ million acquisition of Sanofi's generic drug unit Medley. The company is also preparing to launch its own version of diabetes and weight-loss drug injector pens in Brazil.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773339695216.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773339695216.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773339695216.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773339695216.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773339695216.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":26949,"url":"https:\/\/tvdelmarva.com\/wp\/indian-pharmaceutical-company-prepares-generic-version-of-popular-diabetes-drug\/","url_meta":{"origin":72118,"position":1},"title":"Indian Pharmaceutical Company Prepares Generic Version of Popular Diabetes Drug","author":"Admin","date":"February 25, 2026","format":false,"excerpt":"Dr Reddy's Laboratories plans to introduce a generic alternative to the diabetes medication found in Ozempic and Wegovy next month. The Indian company aims to price their version significantly lower than the brand-name drugs. This comes as patent protections are set to expire in India in 2026.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1772009135958.jpg?fit=450%2C310&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":60532,"url":"https:\/\/tvdelmarva.com\/wp\/canada-authorizes-second-generic-alternative-to-popular-diabetes-drug-ozempic\/","url_meta":{"origin":72118,"position":2},"title":"Canada Authorizes Second Generic Alternative to Popular Diabetes Drug Ozempic","author":"Admin","date":"May 1, 2026","format":false,"excerpt":"Canadian health officials have given the green light to a second generic version of the widely-used diabetes medication Ozempic. The approval for Apotex's semaglutide alternative follows earlier authorization of another copycat version of the Danish pharmaceutical giant's blockbuster drug.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1777668726905.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":70050,"url":"https:\/\/tvdelmarva.com\/wp\/telehealth-company-launches-generic-diabetes-drug-in-canada-after-patent-expires\/","url_meta":{"origin":72118,"position":3},"title":"Telehealth Company Launches Generic Diabetes Drug in Canada After Patent Expires","author":"Admin","date":"May 21, 2026","format":false,"excerpt":"Hims & Hers Health has begun providing Canadians with type 2 diabetes access to a generic version of the diabetes medication semaglutide through its telehealth platform. The move follows the expiration of Novo Nordisk's patent protection, allowing generic drugmakers to enter the Canadian market with lower-cost alternatives.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779374218523.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779374218523.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779374218523.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779374218523.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779374218523.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":40997,"url":"https:\/\/tvdelmarva.com\/wp\/indian-companies-launch-budget-versions-of-popular-weight-loss-drugs\/","url_meta":{"origin":72118,"position":4},"title":"Indian Companies Launch Budget Versions of Popular Weight Loss Drugs","author":"Admin","date":"March 23, 2026","format":false,"excerpt":"Following patent expiration in India, multiple pharmaceutical companies have introduced affordable alternatives to Ozempic and Wegovy, cutting treatment costs by roughly 70%. At least six major Indian drugmakers rolled out their versions over the weekend, with analysts predicting over 40 companies will enter the market. These companies are targeting international\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1774254153131.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":31006,"url":"https:\/\/tvdelmarva.com\/wp\/south-african-company-targets-canadian-market-with-generic-ozempic-alternative\/","url_meta":{"origin":72118,"position":5},"title":"South African Company Targets Canadian Market with Generic Ozempic Alternative","author":"Admin","date":"March 3, 2026","format":false,"excerpt":"A South African pharmaceutical company expects to receive approval for its generic version of the popular diabetes medication Ozempic in Canada by late summer. The move comes after the original patent on the drug's active ingredient expired in January, opening the door for competition.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772549324006.jpg?fit=450%2C272&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/72118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=72118"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/72118\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/72117"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=72118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=72118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=72118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}